Literature DB >> 7948588

Heparin-fibroblast growth factor-fibrin complex: in vitro and in vivo applications to collagen-based materials.

C DeBlois1, M F Côté, C J Doillon.   

Abstract

Biological molecules such as fibrin and growth factors could have interesting features to design bioactive biomaterials and particularly collagen-based materials used as connective tissue replacement. Different combinations of fibroblast growth factor (FGF) and heparin complexed to fibrin were analysed. In vitro, FGF bound to matrix was rapidly, but partially released, specifically with heparin. Heparin concentrations were progressively equilibrated between matrix and medium. DNA replication of fibroblasts grown either on or within fibrin matrices was increased in the presence of both FGF and high doses of heparin incorporated in fibrin. Subcutaneous implantations of collagen sponges impregnated with composite fibrin matrices showed qualitative and quantitative tissue ingrowth within the sponges. The uncross-linked collagen of fibrin-impregnated sponges swelled after implantation. The resulting fibroblast-infiltrated tissue resembled a normal dense connective tissue that was observed particularly in the presence of high doses of heparin and FGF incorporated in fibrin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7948588     DOI: 10.1016/0142-9612(94)90164-3

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

1.  Improved myocardial perfusion and cardiac function by controlled-release basic fibroblast growth factor using fibrin glue in a canine infarct model.

Authors:  Shao-ping Nie; Xiao Wang; Shi-bin Qiao; Qiu-tang Zeng; Ju-quan Jiang; Xiao-qing Liu; Xiang-ming Zhu; Guo-xiang Cao; Chang-sheng Ma
Journal:  J Zhejiang Univ Sci B       Date:  2010-12       Impact factor: 3.066

2.  Delivery system for autologous growth factors fabricated with low-molecular-weight heparin and protamine to attenuate ischemic hind-limb loss in a mouse model.

Authors:  Shingo Nakamura; Megumi Takikawa; Masayuki Ishihara; Takefumi Nakayama; Satoko Kishimoto; Susumu Isoda; Yuichi Ozeki; Masahiro Sato; Tadaaki Maehara
Journal:  J Artif Organs       Date:  2012-08-14       Impact factor: 1.731

3.  FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis.

Authors:  Abha Sahni; Alok A Khorana; Raymond B Baggs; Hu Peng; Charles W Francis
Journal:  Blood       Date:  2005-09-13       Impact factor: 22.113

4.  Attenuation of limb loss in an experimentally induced hindlimb ischemic model by fibroblast growth factor-2/fragmin/protamine microparticles as a delivery system.

Authors:  Shingo Nakamura; Masayuki Ishihara; Megumi Takikawa; Satoko Kishimoto; Susumu Isoda; Masanori Fujita; Masahiro Sato; Tadaaki Maehara
Journal:  Tissue Eng Part A       Date:  2012-08-16       Impact factor: 3.845

5.  In situ loading of basic fibroblast growth factor within porous silica nanoparticles for a prolonged release.

Authors:  Jin Zhang; Lynne-Marie Postovit; Dashan Wang; Richard B Gardiner; Richard Harris; Muminmd Abdul; Anualice Thomas
Journal:  Nanoscale Res Lett       Date:  2009-07-25       Impact factor: 4.703

6.  Biodegradable elastomeric scaffolds with basic fibroblast growth factor release.

Authors:  Jianjun Guan; John J Stankus; William R Wagner
Journal:  J Control Release       Date:  2007-04-13       Impact factor: 9.776

7.  Sustained release and osteogenic potential of heparan sulfate-doped fibrin glue scaffolds within a rat cranial model.

Authors:  Maria Ann Woodruff; Subha Narayan Rath; Evelyn Susanto; Larisa M Haupt; Dietmar W Hutmacher; Victor Nurcombe; Simon M Cool
Journal:  J Mol Histol       Date:  2007-09-12       Impact factor: 3.156

Review 8.  Fibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applications.

Authors:  Thanavel Rajangam; Seong Soo A An
Journal:  Int J Nanomedicine       Date:  2013-09-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.